novavax covid - Search News

News

Novavax, FDA and COVID-19 vaccine

Reuters on MSN · 1d

As FDA delays Novavax' COVID vaccine approval, patients fight back

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F.

Associated Press News on MSN · 1d

Novavax says its COVID-19 shot is on track for full FDA approval after delay

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration.

After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’

The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.

Novavax Booster's Fate in Limbo: FDA Considers Approval Amid Controversy

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

1d

Vertiv earnings beat, DOJ & Disney–fuboTV deal, Novavax COVID shot

Brad Smith outlines the top stories on Wall Street as part of Yahoo Finance's Market Minute. Vertiv Holdings (VRT) stock is ...

Zacks.com on MSN1d

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results